{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:07:29Z","timestamp":1778897249538,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020970","name":"Rashtriya Uchchatar Shiksha Abhiyan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020970","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.peptides.2026.171487","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T07:27:36Z","timestamp":1774682856000},"page":"171487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A chimeric natriuretic peptide (Ev-NP) inhibits isoproterenol (ISO)-induced hypertrophic growth in in vivo and in vitro models by enhancing cGMP and its downstream signaling targets: In silico docking and binding efficacy analysis with NPR-A and NPR-B receptors"],"prefix":"10.1016","volume":"197","author":[{"given":"Jayashree","family":"Bheeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananthan Krishnan","family":"Dhanabalan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopinath","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tharshini","family":"Elangovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhatchana Moorthy","family":"Nachiappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Dhanusu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elangovan","family":"Vellaichamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2026.171487_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.bi.60.070191.001305","article-title":"Atrial natriuretic factor and related peptide hormones","volume":"60","author":"Rosenzweig","year":"1991","journal-title":"Annu. Rev. Biochem."},{"issue":"3","key":"10.1016\/j.peptides.2026.171487_bib2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/01.HYP.0000258532.07418.fa","article-title":"Molecular biology of the natriuretic peptide system: implications for physiology and hypertension","volume":"49","author":"Gardner","year":"2007","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.peptides.2026.171487_bib3","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.peptides.2004.08.027","article-title":"C-type natriuretic peptide and guanylyl cyclase B receptor","volume":"26","author":"Schulz","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2026.171487_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.tem.2005.10.007","article-title":"The endocrine function of the heart","volume":"16","author":"McGrath","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"issue":"1\u20132","key":"10.1016\/j.peptides.2026.171487_bib5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/jme.1.02138","article-title":"Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis","volume":"38","author":"Ellmers","year":"2007","journal-title":"J. Mol. Endocrinol."},{"issue":"11","key":"10.1016\/j.peptides.2026.171487_bib6","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1111\/j.1742-4658.2011.08081.x","article-title":"The functional genomics of guanylyl cyclase\/natriuretic peptide receptor-A: perspectives and paradigms","volume":"278","author":"Pandey","year":"2011","journal-title":"FEBS J."},{"issue":"4","key":"10.1016\/j.peptides.2026.171487_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jash.2008.02.001","article-title":"Emerging roles of natriuretic peptides and their receptors in pathophysiology of hypertension and cardiovascular regulation","volume":"2","author":"Pandey","year":"2008","journal-title":"J. Am. Soc. Hypertens."},{"issue":"1","key":"10.1016\/j.peptides.2026.171487_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/er.2005-0014","article-title":"Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions","volume":"27","author":"Potter","year":"2006","journal-title":"Endocr. Rev."},{"issue":"5","key":"10.1016\/j.peptides.2026.171487_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","article-title":"Natriuretic peptides","volume":"339","author":"Levin","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.peptides.2026.171487_bib10","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1742-4658.2011.08082.x","article-title":"Natriuretic peptide metabolism, clearance and degradation","volume":"278","author":"Potter","year":"2011","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.peptides.2026.171487_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s00395-004-0460-0","article-title":"Molecular physiology of natriuretic peptide signaling","volume":"99","author":"Kuhn","year":"2004","journal-title":"Basic Res. Cardiol."},{"issue":"7","key":"10.1016\/j.peptides.2026.171487_bib12","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/eurheartj\/eht466","article-title":"Natriuretic peptides in cardiovascular diseases: current use and perspectives","volume":"35","author":"Volpe","year":"2013","journal-title":"Eur. Heart J."},{"issue":"8","key":"10.1016\/j.peptides.2026.171487_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1139\/y11-048","article-title":"Designer natriuretic peptides: a vision for the future of heart failure therapeutics","volume":"89","author":"Zakeri","year":"2011","journal-title":"Can. J. Physiol. Pharm."},{"issue":"7","key":"10.1016\/j.peptides.2026.171487_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jacbts.2016.10.001","article-title":"Innovative therapeutics: designer natriuretic peptides","volume":"1","author":"Meems","year":"2016","journal-title":"JACC Basic Transl. Sci."},{"issue":"4","key":"10.1016\/j.peptides.2026.171487_bib15","first-page":"2048","article-title":"Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide","volume":"92","author":"Wei","year":"1993","journal-title":"J. Clin."},{"issue":"3","key":"10.1016\/j.peptides.2026.171487_bib16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11897-010-0016-6","article-title":"CD-NP: an innovative designer natriuretic peptide activator of particulate guanylyl cyclase receptors for cardiorenal disease","volume":"7","author":"McKie","year":"2010","journal-title":"Curr. Heart Fail. Rep."},{"issue":"1","key":"10.1016\/j.peptides.2026.171487_bib17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jacc.2008.02.077","article-title":"Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP","volume":"52","author":"Lisy","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2026.171487_bib18","article-title":"AC-NP: a novel chimeric peptide with natriuretic and vasorelaxing actions","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2026.171487_bib19","article-title":"A new chimeric natriuretic peptide, CNAAC, for the treatment of left ventricular dysfunction after myocardial infarction","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2026.171487_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/0091270009336233","article-title":"Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects","volume":"49","author":"Lee","year":"2009","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.peptides.2026.171487_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/biology11060859","article-title":"Natriuretic peptide-based novel therapeutics: long journeys of drug developments optimized for disease states","volume":"11","author":"Ichiki","year":"2022","journal-title":"Biology"},{"issue":"3","key":"10.1016\/j.peptides.2026.171487_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s12020-024-03849-6","article-title":"Triiodo-L-thyronine (T3) downregulates Npr1 gene (coding for natriuretic peptide receptor-A) transcription in H9c2 cells: involvement of \u03b2-AR-ROS signaling","volume":"85","author":"Nagaraj","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/j.peptides.2026.171487_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.mce.2016.06.010","article-title":"Differential expression and regulation of anti-hypertrophic genes Npr1 and Npr2 during \u03b2-adrenergic receptor activation-induced hypertrophic growth in rats","volume":"433","author":"Manivasagam","year":"2016","journal-title":"Mol. Cell. Endocrinol."},{"issue":"19","key":"10.1016\/j.peptides.2026.171487_bib24","doi-asserted-by":"crossref","first-page":"19230","DOI":"10.1074\/jbc.M411373200","article-title":"Involvement of the NF-kappa B\/matrix metalloproteinase pathway in cardiac fibrosis of mice lacking guanylyl cyclase\/natriuretic peptide receptor A","volume":"280","author":"Vellaichamy","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2026.171487_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.fct.2018.02.016","article-title":"Diet with high content of advanced glycation end products induces systemic inflammation and weight gain in experimental mice: protective role of curcumin and gallic acid","volume":"114","author":"Sowndhar Rajan","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"4","key":"10.1016\/j.peptides.2026.171487_bib26","doi-asserted-by":"crossref","first-page":"F694","DOI":"10.1152\/ajprenal.00097.2003","article-title":"Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion","volume":"285","author":"Shi","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.peptides.2026.171487_bib27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2017.07.042","article-title":"Valporic acid enhances the atrial natriuretic peptide (ANP) mediated anti-hypertrophic activity by modulating the Npr1 gene transcription in H9c2 cells in vitro","volume":"813","author":"Manivasagam","year":"2017","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.peptides.2026.171487_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ejphar.2016.04.037","article-title":"Transient silencing of Npr3 gene expression improved the circulatory levels of atrial natriuretic peptides and attenuated \u03b2-adrenoceptor activation- induced cardiac hypertrophic growth in experimental rats","volume":"782","author":"Venkatesan","year":"2016","journal-title":"Eur. J. Pharm."},{"issue":"7","key":"10.1016\/j.peptides.2026.171487_bib29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3390\/biology11070986","article-title":"CNP, the third natriuretic peptide: its biology and significance to the cardiovascular system","volume":"11","author":"Nakagawa","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.peptides.2026.171487_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/978-3-540-68964-5_15","article-title":"Natriuretic peptides: their structures, receptors, physiological functions and therapeutic applications","volume":"191","author":"Potter","year":"2009","journal-title":"Handb. Exp. Pharm."},{"key":"10.1016\/j.peptides.2026.171487_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108708","article-title":"C-type natriuretic peptide (CNP): the cardiovascular system and beyond","volume":"262","author":"Dickinson","year":"2024","journal-title":"Pharm. Ther."},{"issue":"11","key":"10.1016\/j.peptides.2026.171487_bib32","doi-asserted-by":"crossref","first-page":"9642","DOI":"10.3390\/ijms24119642","article-title":"The natriuretic peptide system: a single entity, pleiotropic functions","volume":"24","author":"Della Corte","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.peptides.2026.171487_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2310\/JIM.0b013e3181946fb2","article-title":"Designer natriuretic peptides","volume":"57","author":"Lee","year":"2009","journal-title":"J. Invest. Med."},{"issue":"11","key":"10.1016\/j.peptides.2026.171487_bib34","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jacc.2009.04.080","article-title":"A human atrial natriuretic peptide gene mutation reveals a novel peptide with enhanced blood pressure-lowering, renal-enhancing, and aldosterone-suppressing actions","volume":"54","author":"McKie","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.peptides.2026.171487_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110648","article-title":"CNP inhibits T3 - induced hypertrophic growth in H9c2 cells: impact of HDAC inhibitor","volume":"775","author":"Nagaraj","year":"2026","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.peptides.2026.171487_bib36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pharmthera.2009.02.009","article-title":"Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics","volume":"122","author":"Tsai","year":"2009","journal-title":"Pharm. Ther."},{"issue":"7544","key":"10.1016\/j.peptides.2026.171487_bib37","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature14332","article-title":"Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease","volume":"519","author":"Lee","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.peptides.2026.171487_bib38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/bbrc.2000.2627","article-title":"Natriuretic peptide receptor-A negatively regulates mitogen-activated protein kinase and proliferation of mesangial cells: role of cGMP-dependent protein kinase","volume":"271","author":"Pandey","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"12","key":"10.1016\/j.peptides.2026.171487_bib39","doi-asserted-by":"crossref","first-page":"6983","DOI":"10.1128\/MCB.18.12.6983","article-title":"Cyclic-GMP-dependent protein kinase inhibits the Ras\/mitogen-activated protein kinase pathway","volume":"18","author":"Suhasini","year":"1998","journal-title":"Mol. Cell. Biol."},{"issue":"16","key":"10.1016\/j.peptides.2026.171487_bib40","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.3390\/ijms20163946","article-title":"Genetic ablation and guanylyl cyclase\/natriuretic peptide receptor-A: impact on the pathophysiology of cardiovascular dysfunction","volume":"20","author":"Pandey KN","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1\u20132","key":"10.1016\/j.peptides.2026.171487_bib41","first-page":"67","article-title":"Angiotensin II down-regulates natriuretic peptide receptor-A expression and guanylyl cyclase activity in H9c2 (2-1) cardiac myoblast cells: role of ROS and NF-\u039ab","volume":"409","author":"Gopi","year":"2015","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.peptides.2026.171487_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijms22010024","article-title":"ANP and BNP exert anti-inflammatory action via NPR-1\/cGMP axis by interfering with canonical, non-canonical, and alternative routes of inflammasome activation in human THP1 cells","volume":"22","author":"Mezzasoma","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.peptides.2026.171487_bib43","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.peptides.2006.12.009","article-title":"Enhanced activation of pro-inflammatory cytokines in mice lacking natriuretic peptide receptor-A","volume":"28","author":"Vellaichamy","year":"2007","journal-title":"Peptides"},{"issue":"2","key":"10.1016\/j.peptides.2026.171487_bib44","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1152\/physrev.00022.2015","article-title":"Molecular physiology of membrane guanylyl cyclase receptors","volume":"96","author":"Kuhn","year":"2016","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.peptides.2026.171487_bib45","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1111\/febs.17104","article-title":"Structural insight into hormone recognition by the natriuretic peptide receptor-A","volume":"291","author":"Ogawa","year":"2024","journal-title":"FEBS J."},{"issue":"27","key":"10.1016\/j.peptides.2026.171487_bib46","doi-asserted-by":"crossref","first-page":"28625","DOI":"10.1074\/jbc.M313222200","article-title":"Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain: rotation mechanism for transmembrane signal transduction","volume":"279","author":"Ogawa","year":"2004","journal-title":"J. Biol. Chem."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978126000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978126000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:11:53Z","timestamp":1778893913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978126000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"alternative-id":["S0196978126000240"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2026.171487","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A chimeric natriuretic peptide (Ev-NP) inhibits isoproterenol (ISO)-induced hypertrophic growth in in vivo and in vitro models by enhancing cGMP and its downstream signaling targets: In silico docking and binding efficacy analysis with NPR-A and NPR-B receptors","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2026.171487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"171487"}}